6-42704564-G-C

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong

The NM_000322.5(PRPH2):​c.629C>G​(p.Pro210Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P210L) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

PRPH2
NM_000322.5 missense

Scores

12
2
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:9O:1

Conservation

PhyloP100: 9.93
Variant links:
Genes affected
PRPH2 (HGNC:9942): (peripherin 2) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein found in the outer segment of both rod and cone photoreceptor cells. It may function as an adhesion molecule involved in stabilization and compaction of outer segment disks or in the maintenance of the curvature of the rim. This protein is essential for disk morphogenesis. Defects in this gene are associated with both central and peripheral retinal degenerations. Some of the various phenotypically different disorders are autosomal dominant retinitis pigmentosa, progressive macular degeneration, macular dystrophy and retinitis pigmentosa digenic. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PM1
In a topological_domain Lumenal (size 140) in uniprot entity PRPH2_HUMAN there are 250 pathogenic changes around while only 6 benign (98%) in NM_000322.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr6-42704564-G-A is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.963
PP5
Variant 6-42704564-G-C is Pathogenic according to our data. Variant chr6-42704564-G-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 13173.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-42704564-G-C is described in Lovd as [Pathogenic]. Variant chr6-42704564-G-C is described in Lovd as [Pathogenic]. Variant chr6-42704564-G-C is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRPH2NM_000322.5 linkc.629C>G p.Pro210Arg missense_variant Exon 2 of 3 ENST00000230381.7 NP_000313.2 P23942
PRPH2XR_007059288.1 linkn.1074C>G non_coding_transcript_exon_variant Exon 3 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRPH2ENST00000230381.7 linkc.629C>G p.Pro210Arg missense_variant Exon 2 of 3 1 NM_000322.5 ENSP00000230381.5 P23942

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461892
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.0000468
Hom.:
0

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2Other:1
Apr 06, 2021
Leiden Open Variation Database
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: curation

Curator: Global Variome, with Curator vacancy. Submitters to LOVD: Julia Lopez, Manon Peeters. -

Mar 02, 2022
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 7519821, 17504850, 11139241, 25082885, 16885924, 21071739, 16799052, 22863181, 7862413, 32531846) -

-
Retina International
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

PRPH2-related disorder Pathogenic:2
Sep 26, 2018
Illumina Laboratory Services, Illumina
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The PRPH2 c.629C>G (p.Pro210Arg) variant is a missense variant that has been reported in four studies, where it was found in a total of six individuals with PRPH2-related disorders, including one homozygote and five heterozygotes (Feist et al. 1994; Gorin et al. 1995; Zhuk et al. 2006; Duncan et al. 2011). The family of one individual reported by Gorin et al. (1995) included at least 10 affected and three unaffected individuals who carried the variant, demonstrating unclear segregation. The p.Pro210Arg variant was absent from 127 controls in the above studies, and it is not reported in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium despite being located in a region of good sequencing coverage. Therefore, the variant is presumed to be rare. Based on the evidence, the p.Pro210Arg variant is classified as likely pathogenic for PRPH2-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 210 of the PRPH2 protein (p.Pro210Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant retinal disease (PMID: 7862413, 11139241, 17504850). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13173). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PRPH2 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -

Vitelliform macular dystrophy 3 Pathogenic:1
Feb 01, 1995
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Patterned dystrophy of the retinal pigment epithelium Pathogenic:1
Jan 07, 2020
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant NM_000322.4:c.629C>G in the PRPH2 gene has been previously studied(PMIDs 7519821, 25082885). We found this variant in 7 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755798,CM941210). It is absent in gnomAD browser. It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PS4, PP1-S, PM1, PM2, PM5, PP3, PP5] and classified NM_000322.4:c.629C>G in the PRPH2 gene as a Pathogenic mutation. -

Vitelliform macular dystrophy 2 Pathogenic:1
Jan 07, 2020
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant NM_000322.4:c.629C>G in the PRPH2 gene has been previously studied(PMIDs 7519821, 25082885). We found this variant in 7 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755798,CM941210). It is absent in gnomAD browser. It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PS4, PP1-S, PM1, PM2, PM5, PP3, PP5] and classified NM_000322.4:c.629C>G in the PRPH2 gene as a Pathogenic mutation. -

Retinal dystrophy Pathogenic:1
Jul 24, 2019
Blueprint Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Stargardt disease Pathogenic:1
Jan 07, 2020
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant NM_000322.4:c.629C>G in the PRPH2 gene has been previously studied(PMIDs 7519821, 25082885). We found this variant in 7 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755798,CM941210). It is absent in gnomAD browser. It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PS4, PP1-S, PM1, PM2, PM5, PP3, PP5] and classified NM_000322.4:c.629C>G in the PRPH2 gene as a Pathogenic mutation. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.47
D
BayesDel_noAF
Pathogenic
0.44
CADD
Pathogenic
33
DANN
Uncertain
1.0
Eigen
Pathogenic
0.93
Eigen_PC
Pathogenic
0.85
FATHMM_MKL
Uncertain
0.97
D
M_CAP
Pathogenic
0.37
D
MetaRNN
Pathogenic
0.96
D
MetaSVM
Pathogenic
0.88
D
PrimateAI
Pathogenic
0.82
D
PROVEAN
Pathogenic
-8.4
D
REVEL
Pathogenic
0.89
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
1.0
MutPred
0.82
Gain of catalytic residue at P210 (P = 0.0759);
MVP
0.99
MPC
1.1
ClinPred
1.0
D
GERP RS
5.1
gMVP
0.98

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61755798; hg19: chr6-42672302; API